Amedeo Smart

Free Medical Literature Service

 

Amedeo

Migraine
  Free Subscription

Articles published in
Neurology
    March 2026
  1. MESSINA R, Christensen RH, Ashina H, Sankar A, et al
    Unveiling Resting-State Functional Connectivity Patterns in Patients With Migraine: A REFORM Study.
    Neurology. 2026;106:e214656.
    >> Share

    February 2026
  2. CARONNA E, Mas-de-Les-Valls R, Egeo G, Millan Vazquez M, et al
    Long-Term Effectiveness and Persistence Factors of Anti-CGRP Monoclonal Antibodies in Migraine: 2-Year Results From the EUREkA Cohort.
    Neurology. 2026;106:e214659.
    >> Share

  3. LUSK JB, Wilson LE, Moore C, Yarnell S, et al
    Calcitonin Gene-Related Peptide Inhibitors and Cardiovascular Events in Patients With Migraine: A Retrospective, Observational Cohort Study.
    Neurology. 2026;106:e214479.
    >> Share

    November 2025
  4. PENG KP, Mehnert J, May A
    Neuronal Dynamics of Menstrually Related Migraine: A Longitudinal Task-Based fMRI Study.
    Neurology. 2025;105:e214234.
    >> Share

  5. COOK JT, Prasad S, Ozudogru S, Ellis CA, et al
    Pearls & Oy-sters: Attacks of Hemiplegic Migraine and Encephalopathy in SLC4A4 Pathogenic Variants.
    Neurology. 2025;105:e214231.
    >> Share

  6. TU YH, Huang TC, Tzeng YS, Chen SP, et al
    Prevalence, Clinical Correlates, and Functional Implications of Vestibular Symptoms in Patients With Migraine.
    Neurology. 2025;105:e214248.
    >> Share

  7. JANG SI, Kim N, Han K, Lee MJ, et al
    Association Between Obesity and the Risk of Migraine: A Nationwide Cohort Study in South Korea.
    Neurology. 2025;105:e214252.
    >> Share

    September 2025
  8. XUAN Z, Pan Z, Ma C, Lin X, et al
    Reader Response: Migraine and Risk of Parkinson Disease in Women: A Cohort Study.
    Neurology. 2025;105:e210094.
    >> Share

  9. SCHULZ RS, Rist PM, Kurth T
    Author Response: Migraine and Risk of Parkinson Disease in Women: A Cohort Study.
    Neurology. 2025;105:e210158.
    >> Share

  10. GANESH A, Galetta SL
    Editors' Note: Migraine and Risk of Parkinson Disease in Women: A Cohort Study.
    Neurology. 2025;105:e214084.
    >> Share

    July 2025
  11. ELLER MT, Schwarzova K, Gufler L, Karisik A, et al
    CGRP-Targeted Migraine Therapies in Patients With Vascular Risk Factors or Stroke: A Review.
    Neurology. 2025;105:e213852.
    >> Share

    June 2025
  12. CAMANNI M, van Gelder MMHJ, Cantarutti A, Nordeng H, et al
    Association of Prenatal Exposure to Triptans, Alone or Combined With Other Migraine Medications, and Neurodevelopmental Outcomes in Offspring.
    Neurology. 2025;104:e213678.
    >> Share

    March 2025
  13. KELLIER D, Anto MM, Hall M, Marin J, et al
    Association of Race and Ethnicity With Emergency Room Rate of Migraine Diagnosis, Testing, and Management in Children With Headache.
    Neurology. 2025;104:e213351.
    >> Share

  14. SCHRAMM S, Borner-Schroder C, Reichert M, Ramschutz C, et al
    Consensus Recommendations to Establish Reporting Standards in fMRI of Migraine: A Delphi Study.
    Neurology. 2025;104:e210235.
    >> Share

    February 2025
  15. HOFFMANN J, Kaube H, Rimmele F, Jurgens TP, et al
    Kinetic Oscillation Stimulation for the Preventive Treatment of Chronic Migraine: A Randomized, Double-Blind, Sham-Controlled Trial.
    Neurology. 2025;104:e210220.
    >> Share

    January 2025
  16. LIPTON RB, Gandhi P, Tassorelli C, Reuter U, et al
    Early Improvements With Atogepant for the Preventive Treatment of Migraine: Results From 3 Randomized Phase 3 Trials.
    Neurology. 2025;104:e210212.
    >> Share

  17. LUBOTZKY A, Pai V, Branson HM, Chowdhury SS, et al
    Teaching NeuroImage: Stroke-Like Migraine Attacks After Radiation Therapy Syndrome.
    Neurology. 2025;104:e210203.
    >> Share

    December 2024
  18. BONNESEN K, Fuglsang CH, Schmidt M
    Impact of Nonsteroidal Anti-Inflammatory Drug Use on the Migraine-Associated Risk of Myocardial Infarction and Ischemic Stroke: A Population-Based Cohort Study.
    Neurology. 2024;103:e210034.
    >> Share

  19. WANG K, Sico JJ
    Treating Migraine Patients With Cardiovascular Risks: Are NSAIDs the Safer Choice?
    Neurology. 2024;103:e210196.
    >> Share

    November 2024

  20. Efficacy of Atogepant in Chronic Migraine With and Without Acute Medication Overuse in the Randomized, Double-Blind, Phase 3 PROGRESS Trial.
    Neurology. 2024;103:e209868.
    >> Share

  21. ALLEN C, Rastall DP
    Teaching NeuroImage: Alice in Wonderland Syndrome: Anatomic Correlation.
    Neurology. 2024;103:e209957.
    >> Share


  22. Sex-Specific Association of Cardiovascular Risk Factors With Migraine: The Population-Based Rotterdam Study.
    Neurology. 2024;103:e210022.
    >> Share

    September 2024
  23. KUMAR A, Joshi D, Singh VK
    Harlequin Syndrome: A Rare Association With Migraine.
    Neurology. 2024;103:e209792.
    >> Share

  24. SCHULZ RS, Glatz T, Buring JE, Rist PM, et al
    Migraine and Risk of Parkinson Disease in Women: A Cohort Study.
    Neurology. 2024;103:e209747.
    >> Share

  25. LIPTON RB, Harriott AM, Ma JY, Smith JH, et al
    Effect of Ubrogepant on Patient-Reported Outcomes When Administered During the Migraine Prodrome: Results From the Randomized PRODROME Trial.
    Neurology. 2024;103:e209745.
    >> Share

    August 2024
  26. AL-HASSANY L, Acarsoy C, Ikram MK, Bos D, et al
    Sex-Specific Association of Cardiovascular Risk Factors With Migraine: The Population-Based Rotterdam Study.
    Neurology. 2024;103:e209700.
    >> Share

    July 2024
  27. GOADSBY PJ, Friedman DI, Holle-Lee D, Demarquay G, et al
    Efficacy of Atogepant in Chronic Migraine With and Without Acute Medication Overuse in the Randomized, Double-Blind, Phase 3 PROGRESS Trial.
    Neurology. 2024;103:e209584.
    >> Share

    May 2024
  28. CHRISTENSEN RH, Ashina H, Al-Khazali HM, Zhang Y, et al
    Differences in Cortical Morphology in People With and Without Migraine: A Registry for Migraine (REFORM) MRI Study.
    Neurology. 2024;102:e209305.
    >> Share

  29. REUTER U, Goadsby PJ, Ferrari MD, Da Silva Lima GP, et al
    Efficacy and Safety of Erenumab in Participants With Episodic Migraine in Whom 2-4 Prior Preventive Treatments Had Failed: LIBERTY 3-Year Study.
    Neurology. 2024;102:e209349.
    >> Share

    April 2024
  30. DE HAVENON A, Callaghan BC, Xu Y, Connor M, et al
    Burden of Neurologic Health Care and Incident Neurologic Diagnoses in the Year After COVID-19 or Influenza Hospitalization.
    Neurology. 2024;102:e209248.
    >> Share

  31. VAN OOSTERHOUT WPJ, Perenboom MJL, Terwindt GM, Ferrari MD, et al
    Frequency and Clinical Features of Space Headache Experienced by Astronauts During Long-Haul Space Flights.
    Neurology. 2024;102:e209224.
    >> Share

  32. PETROVA M, Besedina O, Hare B, Gupta A, et al
    Comprehensive Analysis of Migraine Burden and Treatment Trends: A Retrospective Cohort Study of Recent Large Multiple Commercial Payer Databases. (P9-12.005).
    Neurology. 2024;102.
    >> Share

  33. BLUMENFELD A, Mechtler L, Cook L, Rhyne C, et al
    Real-world Evidence of Adding Atogepant to OnabotulinumtoxinA for Control of Chronic Migraine: A Retrospective Chart Review (P4-12.001).
    Neurology. 2024;102.
    >> Share

    February 2024
  34. LATEEF TM, Dey D, Leroux A, Cui L, et al
    Association Between Electronic Diary-Rated Sleep, Mood, Energy, and Stress With Incident Headache in a Community-Based Sample.
    Neurology. 2024;102:e208102.
    >> Share

  35. PIZER JH, Aita SL, Myers MA, Hawley NA, et al
    Neuropsychological Function in Migraine Headaches: An Expanded Comprehensive Multidomain Meta-Analysis.
    Neurology. 2024;102:e208109.
    >> Share

  36. SHAPIRO RE, Nicholson RA, Seng EK, Buse DC, et al
    Migraine-Related Stigma and Its Relationship to Disability, Interictal Burden, and Quality of Life.
    Neurology. 2024;102:e208074.
    >> Share

  37. KEMPNER J
    Brains Under Siege: Assessing the Harmful Effects of Migraine-Related Stigma.
    Neurology. 2024;102:e209192.
    >> Share

    January 2024
  38. HVITFELDT FUGLSANG C, Pedersen L, Schmidt M, Vandenbroucke JP, et al
    Combined Impact of Migraine and Pregnancy-Induced Hypertension on Long-term Risk of Premature Myocardial Infarction and Stroke.
    Neurology. 2024;102:e207813.
    >> Share

    November 2023
  39. CHIANG CC, Fang X, Horvath Z, Cadiou F, et al
    Simultaneous Comparisons of 25 Acute Migraine Medications Based on 10 Million Users' Self-Reported Records From a Smartphone Application.
    Neurology. 2023 Nov 29:10.1212/WNL.0000000000207964.
    >> Share

  40. FRIEDMAN SA, Robbins MS
    Millions of Migraine Attacks, Many Answers, More Questions.
    Neurology. 2023 Nov 29:10.1212/WNL.0000000000208084.
    >> Share

    August 2023
  41. FRIEDMAN BW, Solorzano C, Kessler BD, Martorello K, et al
    Randomized Trial Comparing Low- vs High-Dose IV Dexamethasone for Patients With Moderate to Severe Migraine.
    Neurology. 2023 Aug 21:10.1212/WNL.0000000000207648.
    >> Share

  42. VANDERPLUYM JH, Victorio MCC, Oakley CB, Rastogi RG, et al
    Beyond the Guidelines: A Narrative Review of Treatments on the Horizon for Migraine in Children and Adolescents.
    Neurology. 2023 Aug 21:10.1212/WNL.0000000000207677.
    >> Share

    July 2023
  43. VANDERPLUYM JH
    Variation in Endpoints in FDA Approvals for Acute and Preventive Migraine Medications: Striving to Compare Apples to Apples.
    Neurology. 2023 Jul 12:10.1212/WNL.0000000000207672.
    >> Share

  44. SHARPLESS LK, Kesselheim A, Orr SL, Darrow J, et al
    Variation in Endpoints in FDA Medication Approvals: A Review of Acute and Preventive Migraine Medications.
    Neurology. 2023 Jul 12:10.1212/WNL.0000000000207544.
    >> Share

  45. PONDER M, Wood ME
    Periconceptional Use of OnabotulinumtoxinA: Need for Comparative Safety Studies.
    Neurology. 2023;101:53-54.
    >> Share

    June 2023
  46. LIU J, Quan S, Zhao L, Yuan K, et al
    Evaluation of a Clustering Approach to Define Distinct Subgroups of Patients With Migraine to Select Electroacupuncture Treatments.
    Neurology. 2023 Jun 22:10.1212/WNL.0000000000207484.
    >> Share

    May 2023
  47. ORNELLO R, Sposato LA, Sacco S
    Author Response: Microembolism and Other Links Between Migraine and Stroke: Clinical and Pathophysiologic Update.
    Neurology. 2023;100:1033.
    >> Share

  48. LEWIS A, Galetta S
    Editors' Note: Microembolism and Other Links Between Migraine and Stroke: Clinical and Pathophysiologic Update.
    Neurology. 2023;100:1032.
    >> Share

  49. SCUTELNIC A, Jung S, Schankin CJ
    Reader Response: Microembolism and Other Links Between Migraine and Stroke: Clinical and Pathophysiologic Update.
    Neurology. 2023;100:1032-1033.
    >> Share

    April 2023
  50. KARCESKI S
    Migraine and Hormones: A Complex Interaction.
    Neurology. 2023;100:e1849-e1851.
    >> Share

  51. BARBANTI P, Aurilia C, Egeo G, Torelli P, et al
    Late Response to Anti-CGRP Monoclonal Antibodies in Migraine: A Multicenter, Prospective, Observational Study.
    Neurology. 2023 Apr 18:10.1212/WNL.0000000000207292.
    >> Share


  52. Efficacy and Safety of Eptinezumab in Patients With Chronic Migraine: PROMISE-2.
    Neurology. 2023 Apr 4:10.1212/WNL.0000000000207168.
    >> Share

    March 2023
  53. BENKLI B, Kim SY, Koike N, Han C, et al
    Circadian Features of Cluster Headache and Migraine: A Systematic Review, Meta-analysis, and Genetic Analysis.
    Neurology. 2023 Mar 29:10.1212/WNL.0000000000207240.
    >> Share

  54. SUTHERLAND H, Griffiths L
    It's All About the Timing: Circadian Factors in Cluster Headache and Migraine.
    Neurology. 2023 Mar 29:10.1212/WNL.0000000000207329.
    >> Share

    August 2022
  55. ADDERLEY NJ, Subramanian A, Perrins M, Nirantharakumar K, et al
    Headache, Opiate Use, and Prescribing Trends in Women With Idiopathic Intracranial Hypertension: A Population-Based Matched Cohort Study.
    Neurology. 2022 Aug 19. pii: WNL.0000000000201064.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016